Form 4: Teladoc Health CFO Mala Murthy Reports Acquisition of 110,800 Restricted Stock Units

Teladoc Health's CFO, Mala Murthy, reported the acquisition of 110,800 restricted stock units (RSUs) on March 19, 2024.

Summary

• On March 19, 2024, Mala Murthy, the Chief Financial Officer of Teladoc Health, Inc. [TDOC], acquired 110,800 restricted stock units.
• These restricted stock units represent a contingent right to receive one share of TDOC common stock each.
• The vesting schedule for these RSUs is as follows: one-third vests on the first anniversary of the grant date, and the remaining units vest in eight substantially equal quarterly installments starting on June 1, 2025.
• Following this transaction, Ms. Murthy directly owns 110,800 derivative securities.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of RSUs by the CFO suggests confidence in the company's future performance, but it's a routine transaction.

Positives

• The acquisition of restricted stock units by the CFO aligns her interests with those of the shareholders, incentivizing her to work towards the company's success.

Future Outlook

The vesting schedule indicates a long-term commitment by the CFO to the company's future.

Industry Context

Equity compensation is a common practice in the healthcare technology industry to attract and retain top talent.

Stakeholder Impact

• The acquisition of RSUs by the CFO aligns her interests with those of the shareholders.

Key Dates